ArticleJournal of ovarian research2026
miR-378a-3p participates in the decline of ovarian reserve function by targeting ZFP36L2 to regulate granulosa cell mitochondrial function and apoptosis.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiminished ovarian reserve (DOR) is associated with impaired female fertility; however, its molecular mechanisms remain incompletely understood. Our previous studies found that individuals with DOR have lower levels of microRNA-378a-3p (miR-378a-3p) expression in their granulosa cells (GCs), yet its role in DOR has not been investigated in depth.
objectiveTo explore the effects of miR-378a-3p on apoptosis and mitochondrial function in the pathogenesis of DOR.
methodsIdentifying the target gene of miR-378a-3p using bioinformatics prediction and dual-luciferase reporter gene analysis, and its expression was quantitatively assessed using qRT-PCR and Western blotting. By transfection of KGN cells to alter the level of miR-378a-3p expression. The role of miR-378a-3p in mitochondrial function and GC apoptosis was investigated via flow cytometry. The levels of miR-378a-3p and its target genes in GCs from patients with DOR and normal ovarian reserve (NOR) were examined, and their expression levels and correlation with assisted reproductive technology (ART) outcomes were explored.
resultsmiR-378a-3p directly bound to the 3'UTR of ZFP36L2, confirming ZFP36L2 as its direct target. Compared to the negative control group, inhibition of miR-378a-3p resulted in a marked decrease in mitochondrial membrane potential (MMP) (P < 0.05), along with a significant elevation in reactive oxygen species (ROS) levels (P < 0.05) and a reduction in mitochondrial DNA (mtDNA) content (P < 0.05). Furthermore, transfection with the miR-378a-3p inhibitor significantly reduced the proportion of viable cells and increased the percentages of both early and late apoptotic cells (P < 0.05). miR-378a-3p expression in the DOR group was significantly lower than in the NOR group (P < 0.01), while ZFP36L2 mRNA and protein were significantly upregulated (P < 0.01). ZFP36L2 mRNA in GCs was strongly negatively correlated with miR-378a-3p (r = -0.874, P < 0.01). Furthermore, the expression level of miR-378a-3p showed significant positive correlations with basal ovarian reserve markers AMH (r = 0.736, P < 0.001) and AFC (r = 0.774, P < 0.001), and was also positively correlated with better clinical assisted reproductive outcome parameters, particularly evidenced by a higher quantity of retrieved oocytes (r = 0.680, P < 0.001) and embryos (r = 0.575, P < 0.001).
conclusionmiR-378a-3p promotes mitochondrial dysfunction and apoptosis in GC by targeting ZFP36L2, and may be involved in the pathogenesis of DOR. This study provides new clues for the molecular mechanism of DOR, but has limitations such as the need for additional rescue/interaction experiments and animal studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.